Pneumococcal 21-valent Conjugate Vaccine

Generic Name: pneumococcal 21-valent conjugate vaccine

Over-the-Counter (OTC)

Brand Names:

Capvaxive

Dosage form: INJECTION, SOLUTION. Route: INTRAMUSCULAR. Active ingredients: CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN (65 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 15A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 16F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 20A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 23A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 23B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 24F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 31 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 35B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL); STREPTOCOCCUS PNEUMONIAE TYPE DEOAC15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN (4 ug/.5mL). Category: BLA.

Overview

Dosage

Available as injection, solution for intramuscular use.

Related Medications

Chamomilla, Echinacea, Iris Versicolor, Ruta Graveolens, Taraxacum Officinale, Antimonium Crudum, Arsenicum Album, Baptisia Tinctoria, Bryonia, Carbo Vegetabilis, Chelidonium Majus, Cinchona Officinalis, Colchicum Autumnale, Daphne Indica, Ipecacuanha, Iris Versicolor, Kali Carbonicum, Kreosotum, Lachesis Mutus, Lycopodium Clavatum, Magnesia Carbonica, Mercurius Vivus, Nux Vomica, Phosphorus, Pulsatilla, Spigelia Anthelmia, Sulphur, Pyrogenium

chamomilla, echinacea, iris versicolor, ruta graveolens, taraxacum officinale, antimonium crudum, arsenicum album, baptisia tinctoria, bryonia, carbo vegetabilis, chelidonium majus, cinchona officinalis, colchicum autumnale, daphne indica, ipecacuanha, iris versicolor, kali carbonicum, kreosotum, lachesis mutus, lycopodium clavatum, magnesia carbonica, mercurius vivus, nux vomica, phosphorus, pulsatilla, spigelia anthelmia, sulphur, pyrogenium

Non-Standardized Plant Allergenic Extract [EPC]

OTC - PURPOSE SECTION Formulated for associated symptoms such as bloating, nausea, eructations and pain or burning sensation in the upper abdomen

Tisagenlecleucel

tisagenlecleucel

CD19-directed Chimeric Antigen Receptor [EPC]

11 DESCRIPTION KYMRIAH (tisagenlecleucel) is a CD19-directed genetically modified autologous T cell immunotherapy comprised of autologous T cells that are genetically modified using a lentiviral vector to encode an anti-CD19 chimeric antigen receptor (CAR). The CAR is comprised of a murine single-chain antibody fragment (scFv) specific for CD19, followed by a CD8 hinge and transmembrane region that is fused to the intracellular signaling domains for 4-1BB (CD137) and CD3 zeta.

Melaleuca, Melaleuca Quinquenervia

melaleuca, melaleuca quinquenervia

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: MELALEUCA QUINQUENERVIA POLLEN (.05 g/mL). Category: BLA.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.